Detalles de la búsqueda
1.
Pre-encoded responsiveness to type I interferon in the peripheral immune system defines outcome of PD1 blockade therapy.
Nat Immunol
; 23(8): 1273-1283, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35835962
2.
Comparison of outcomes for Hispanic and non-Hispanic patients with advanced renal cell carcinoma in the International Metastatic Renal Cell Carcinoma Database.
Cancer
; 130(11): 2003-2013, 2024 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38297953
3.
Prospective manipulation of the gut microbiome with microbial ecosystem therapeutic 4 (MET4) in HPV-related locoregionally-advanced oropharyngeal cancer squamous cell carcinoma (LA-OPSCC) undergoing primary chemoradiation: ROMA2 study.
Br J Cancer
; 2024 May 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-38714747
4.
INDUCE-2: A Phase I/II, open-label, two-part study of feladilimab in combination with tremelimumab in patients with advanced solid tumors.
Cancer Immunol Immunother
; 73(3): 44, 2024 Feb 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-38349570
5.
A phase 1 trial of the MEK inhibitor selumetinib in combination with pembrolizumab for advanced or metastatic solid tumors.
Invest New Drugs
; 2024 Mar 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-38483782
6.
CXCR2 antagonist navarixin in combination with pembrolizumab in select advanced solid tumors: a phase 2 randomized trial.
Invest New Drugs
; 42(1): 145-159, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38324085
7.
The role of cytoreductive nephrectomy and systemic therapy in the management of tumour thrombus in patients with metastatic renal cell carcinoma.
Br J Cancer
; 128(10): 1888-1896, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36859686
8.
A tailored phase I-specific patient-reported outcome (PRO) survey to capture the patient experience of symptomatic adverse events.
Br J Cancer
; 129(4): 612-619, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37419999
9.
Characterization of Patients With Metastatic Renal Cell Carcinoma Experiencing Complete Response to First-line Therapies: Results From the International Metastatic Renal Cell Carcinoma Database Consortium.
J Urol
; 209(4): 701-709, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36573926
10.
Longitudinal health utility and symptom-toxicity trajectories in patients with head and neck cancers.
Cancer
; 128(3): 497-508, 2022 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34597435
11.
Evaluation of the patient experience of symptomatic adverse events on Phase I clinical trials using PRO-CTCAE.
Br J Cancer
; 127(9): 1629-1635, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36008705
12.
Health-related quality-of-life assessment of patients with solid tumors on immuno-oncology therapies.
Cancer
; 127(9): 1360-1368, 2021 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33662145
13.
Examining the ability of the Cancer and Aging Research Group tool to predict toxicity in older men receiving chemotherapy or androgen-receptor-targeted therapy for metastatic castration-resistant prostate cancer.
Cancer
; 127(14): 2587-2594, 2021 07 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33798267
14.
Transitions in oral and gut microbiome of HPV+ oropharyngeal squamous cell carcinoma following definitive chemoradiotherapy (ROMA LA-OPSCC study).
Br J Cancer
; 124(9): 1543-1551, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33750907
15.
Phase II Trial of Symptom Screening With Targeted Early Palliative Care for Patients With Advanced Cancer.
J Natl Compr Canc Netw
; 20(4): 361-370.e3, 2021 09 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34492632
16.
The financial impact of cancer care on renal cancer patients.
Can J Urol
; 28(4): 10762-10767, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34378512
17.
Hypofractionated radiotherapy alone with 2.4 Gy per fraction for head and neck cancer during the COVID-19 pandemic: The Princess Margaret experience and proposal.
Cancer
; 126(15): 3426-3437, 2020 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32478895
18.
Development of the Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator (FACT-ICM): A toxicity subscale to measure quality of life in patients with cancer who are treated with ICMs.
Cancer
; 126(7): 1550-1558, 2020 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31914209
19.
Real-World Assessment of Clinical Outcomes Among First-Line Sunitinib Patients with Clear Cell Metastatic Renal Cell Carcinoma (mRCC) by the International mRCC Database Consortium Risk Group.
Oncologist
; 25(5): 422-430, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31971318
20.
A phase 2 trial of sunitinib in patients with progressive paraganglioma or pheochromocytoma: the SNIPP trial.
Br J Cancer
; 120(12): 1113-1119, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31105270